Somatic EP300 mutation is primarily seen in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), resulting in abnormal acetylation of p53 and BCL6 and thereby promoting tumorigenesis (35). This evidence concerns the gene EP300 and diffuse large B-cell lymphoma.